Neoleukin: 3Q Earnings Snapshot
VANCOUVER, British Columbia (AP) _ Neoleukin Therapeutics, Inc. (NLTX) on Wednesday reported a loss of $59.1 million in its third quarter.
The Vancouver, British Columbia-based company said it had a loss of $2.26 per share. Losses, adjusted for non-recurring costs, were 44 cents per share.
The company’s shares closed at $2.98. A year ago, they were trading at $2.26.